Literature DB >> 27568557

Identification of Modifier Genes in a Mouse Model of Gaucher Disease.

Andrés D Klein1, Natalia-Santos Ferreira1, Shifra Ben-Dor2, Jingjing Duan3, John Hardy4, Timothy M Cox5, Alfred H Merrill3, Anthony H Futerman6.   

Abstract

Diseases caused by single-gene mutations can display substantial phenotypic variability, which may be due to genetic, environmental, or epigenetic modifiers. Here, we induce Gaucher disease (GD), a rare inherited metabolic disorder, by injecting 15 inbred mouse strains with a low dose of a chemical inhibitor of acid β-glucosidase, the enzyme defective in GD. Different mouse strains exhibit widely different lifespans, which is unrelated to levels of acid β-glucosidase's substrate accumulation. Genome-wide association reveals a number of candidate risk loci, including a marker within Grin2b, which in combination with another marker allows us to predict the lifespan of additional mouse strains. An antagonist of the NMDA receptor (encoded by Grin2b) significantly increases the lifespan of GD mice that would otherwise have lived for a short time. Our data identify putative modifier genes that may be involved in determining GD severity, which might help elucidate phenotypic variability between patients with similar GD mutations.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27568557     DOI: 10.1016/j.celrep.2016.07.085

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  21 in total

Review 1.  Exploring genetic modifiers of Gaucher disease: The next horizon.

Authors:  Brad A Davidson; Shahzeb Hassan; Eric Joshua Garcia; Nahid Tayebi; Ellen Sidransky
Journal:  Hum Mutat       Date:  2018-09-11       Impact factor: 4.878

2.  Perspective: Finding common ground.

Authors:  Anthony H Futerman; John Hardy
Journal:  Nature       Date:  2016-09-22       Impact factor: 49.962

3.  Recent advances in the diagnosis and management of Gaucher disease.

Authors:  Sam E Gary; Emory Ryan; Alta M Steward; Ellen Sidransky
Journal:  Expert Rev Endocrinol Metab       Date:  2018-03-12

Review 4.  Gaucher disease: Progress and ongoing challenges.

Authors:  Pramod K Mistry; Grisel Lopez; Raphael Schiffmann; Norman W Barton; Neal J Weinreb; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2016-11-17       Impact factor: 4.797

5.  Is Parkinson's disease a lysosomal disorder?

Authors:  Andrés D Klein; Joseph R Mazzulli
Journal:  Brain       Date:  2018-08-01       Impact factor: 13.501

6.  Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model.

Authors:  Nicole K Polinski; Terina N Martinez; Alexander Gorodinsky; Ralph Gareus; Michael Sasner; Mark Herberth; Robert Switzer; Syed O Ahmad; Mali Cosden; Monika Kandebo; Robert E Drolet; Peter D Buckett; Weisong Shan; Yi Chen; Lee J Pellegrino; Gregory D Ellsworth; Leo B Dungan; Warren D Hirst; Sean W Clark; Kuldip D Dave
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.240

7.  Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Alexandre Henriques; Mylene Huebecker; Hélène Blasco; Céline Keime; Christian R Andres; Philippe Corcia; David A Priestman; Frances M Platt; Michael Spedding; Jean-Philippe Loeffler
Journal:  Sci Rep       Date:  2017-07-12       Impact factor: 4.379

8.  Gadolinium Chloride Rescues Niemann⁻Pick Type C Liver Damage.

Authors:  Andrés D Klein; Juan Esteban Oyarzún; Cristian Cortez; Silvana Zanlungo
Journal:  Int J Mol Sci       Date:  2018-11-14       Impact factor: 5.923

9.  Glucosylsphingosine Causes Hematological and Visceral Changes in Mice-Evidence for a Pathophysiological Role in Gaucher Disease.

Authors:  Jan Lukas; Claudia Cozma; Fan Yang; Guido Kramp; Anja Meyer; Anna-Maria Neßlauer; Sabrina Eichler; Tobias Böttcher; Martin Witt; Anja U Bräuer; Peter Kropp; Arndt Rolfs
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

10.  Innate immune response in neuronopathic forms of Gaucher disease confers resistance against viral-induced encephalitis.

Authors:  Sharon Melamed; Roy Avraham; Deborah E Rothbard; Noam Erez; Tomer Israely; Ziv Klausner; Anthony H Futerman; Nir Paran; Einat B Vitner
Journal:  Acta Neuropathol Commun       Date:  2020-08-24       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.